A pregnancy and children follow-up study of three randomised clinical trials with recombinant follicle-stimulating hormone (Puregon®) in in-vitro fertilisation

Middle East Fertility Society Journal

Volumn 4, Issue 1, 1999, Pages 28-34

  Out, H J ^a   Driessen, S G A J ^a   Mannaerts, B M J L ^a   Coelingh Bennink, H J T ^a  

^a NV ORGANON   (Netherlands)

Author keywords

Follow up; Pregnancies; Puregon ; Recombinant FSH

Indexed keywords

BUSERELIN; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN; TRIPTORELIN; UROFOLLITROPIN;

ARTICLE; CHILD; CLINICAL TRIAL; CONGENITAL MALFORMATION; FEMALE; FERTILIZATION IN VITRO; FOLLOW UP; GESTATIONAL AGE; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSTETRIC CARE; PREMATURE FETUS MEMBRANE RUPTURE; SMALL FOR DATE INFANT; TREATMENT OUTCOME;

EID: 0032942711     PISSN: 11105690     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)